시장보고서

상품코드

1941359

폐 마커 시장 보고서 : 암종별, 마커 유형별, 최종사용자별, 지역별(2026-2034년)

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2026-2034

발행일: 2026년 02월 | 리서치사:

IMARC | 페이지 정보: 영문 147 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 폐 마커 시장 규모는 2025년에 5억 2,850만 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 11억 6,850만 달러에 달하고, 2026년부터 2034년까지 CAGR 8.8%로 성장할 것으로 예측하고 있습니다.

일반적으로 폐 마커자는 EGFR, EML4-ALK, KRAS, BRAF 등 4가지 주요 유형이 있으며, 폐중재술, 폐수술, 진단에 사용됩니다. 또한, 이러한 마커는 종양의 발견, 진단, 예측, 경과관찰에 사용되며, 그 결과에 따라 환자에게 치료법을 처방합니다. 폐 마커는 여러 영상 검사 및 생검과 함께 암을 식별하기 위한 보조 도구로만 사용됩니다. 이 때문에 폐 마커는 병원, 외래 수술 클리닉, 전문 클리닉을 비롯한 다양한 헬스케어 시설에서 흉강경 수술에 널리 활용되고 있습니다.

폐 마커에 대한 수요 증가는 전 세계 대기오염 악화에 따른 흉수, 흉막중피종, 흉막 플라크 등 호흡기질환의 빈번한 발생에 기인합니다. 또한, 간접흡연에 대한 높은 노출과 폐암의 가족력이 폐암 환자의 수를 더욱 증가시켜 폐암 마커에 대한 수요 확대를 촉진하고 있습니다. 또한, 고령화 인구의 급증과 바쁜 소비생활로 인한 높은 흡연율은 여러 호흡기질환의 위험을 더욱 가속화시키고 있습니다. 이와 더불어 폐암 등 생명을 위협하는 질환의 조기 진단 및 치료를 위한 각국 정부의 의료비 지출 증가도 전 세계적으로 폐 마커의 활용 확대를 촉진하고 있습니다. 또한, 폐암 진단 및 치료 분야의 연구개발 활동에 대한 투자 증가는 폐암 마커에 대한 수요를 더욱 촉진하고 있습니다. 또한, 병원, 수술 센터, 클리닉에서 폐 마커의 사용 확대와 치료 목적의 다양한 적용도 제품 수요를 견인하고 있습니다.

본 보고서에서 답변하는 주요 질문:

지금까지의 세계 폐 마커 시장 동향과 향후 몇 년간의 시장 동향은 어떻게 될 것으로 예상되는가?
COVID-19는 세계 폐 마커 시장에 어떤 영향을 미쳤는가?
주요 지역 시장은 어디인가?
암종별 시장 현황은 어떻게 되는가?
마커의 종류별 시장 현황은 어떻게 되는가?
최종사용자별 시장 현황은 어떻게 되는가?
산업 가치사슬의 각 단계는 무엇일까?
업계의 주요 촉진요인과 도전 과제는 무엇인가?
세계 폐 마커 시장의 구조와 주요 플레이어는 무엇인가?
업계 내 경쟁의 정도는 어느 정도인가요?

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

Breakup by Cancer Type:

Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

EGFR
EML4-ALK
KRAS
BRAF
Others

Breakup by End User:

Hospitals
Diagnostic Labs
Others

Breakup by Region:

North America
- United States
- Canada
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- Others
Middle East and Africa
- Turkey
- Iran
- Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:

How has the global lung marker market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global lung marker market?
What are the key regional markets?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the marker type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global lung marker market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Lung Marker Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact Of COVID-19
5.4 Market Forecast

6 Market Breakup by Cancer Type

6.1 Non-Small Cell Lung Cancer (NSCLC)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Small Cell Lung Cancer (SCLC)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Marker Type

7.1 EGFR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 EML4-ALK
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 KRAS
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 BRAF
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Diagnostic Labs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Europe
- 9.2.1 Germany
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 France
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 United Kingdom
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 Italy
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Spain
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Russia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Asia Pacific
- 9.3.1 China
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 Japan
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 India
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 South Korea
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Australia
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Indonesia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Argentina
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
- 9.4.4 Colombia
  - 9.4.4.1 Market Trends
  - 9.4.4.2 Market Forecast
- 9.4.5 Chile
  - 9.4.5.1 Market Trends
  - 9.4.5.2 Market Forecast
- 9.4.6 Peru
  - 9.4.6.1 Market Trends
  - 9.4.6.2 Market Forecast
- 9.4.7 Others
  - 9.4.7.1 Market Trends
  - 9.4.7.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Turkey
  - 9.5.1.1 Market Trends
  - 9.5.1.2 Market Forecast
- 9.5.2 Iran
  - 9.5.2.1 Market Trends
  - 9.5.2.2 Market Forecast
- 9.5.3 Others
  - 9.5.3.1 Market Trends
  - 9.5.3.2 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Thermo Fisher Scientific Inc
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Agilent Technologies, Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Beckman Coulter, Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Fujirebio Europe N.V.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Hologic, Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 F. Hoffmann-La Roche Ltd
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Siemens Healthineers
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 BioSpace, Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis

폐 마커 시장 보고서 : 암종별, 마커 유형별, 최종사용자별, 지역별(2026-2034년)

Lung Marker Market Report by Cancer Type (Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)), Marker Type (EGFR, EML4-ALK, KRAS, BRAF, and Others), End User (Hospitals, Diagnostic Labs, and Others), and Region 2026-2034

본 보고서에서 답변하는 주요 질문:

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 폐 마커 시장

제6장 시장 내역 : 암종별

제7장 시장 내역 : 마커 유형별

제8장 시장 내역 : 최종사용자별

제9장 시장 내역 : 지역별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter's Five Forces 분석

제13장 가격 지표

제14장 경쟁 구도